Role of Vitamin-D and Oxidative Stress in Polycystic Ovarian Syndrome with Rheumatoid Arthritis

DATE PUBLISHED
March 16, 2020
SECTION
Articles

Abstract

Aim and objectives: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder. Metabolic disturbances including hyperinsulinemia, dyslipidemia and insulin resistance,  are common features in the majority of PCOS women.  Women  with  PCOS  may  also  be  at  increased  risk  of  vitamin  D deficiency. Several studies have reported that lower vitamin D levels are associated with increased risk of insulin resistance and metabolic disturbance among women with PCOS . The objective of the study was to evaluate the relationship between vitamin D and oxidative stress in pcos with RA

Materials And Methods : The study includes 20 healthy control women,  and 20 were with PCOS with rheumatoid arthritis .Total sample size was 40. Vitamin D total is estimated by chemiluminescent immunoassay and to assess oxidative stress, serum Malonyldialdehyde (MDA) was done by thiobarbituric acid method and antioxidant level was assessed by estimation of serum vitamin C by dinitrophenyl hydrazine method.

Results: There was a decrease of vitamin -D in PCOS with RA (30.5 ±1.6), when compared with control(59.8 ±2.8). It was statistically significant (P<0.001). There was a decrease in vitamin -C in PCOS with RA (0.7 ±0.07) when compared with controls(1.1± 0.08). It was statistically significant (P<0.001). There was a increase of MDA in PCOS with RA, (9.0± 0.6) when compared with control (3.8± 0.2). It was statistically significant (P<0.001).

Conclusion: Low levels of Vitamin D deficiency in PCOS with RA patients is associated with inflammation which leads to Increased oxidative stress status , which may lead to connective tissue degradation leading to joint and periarticular deformities in rheumatoid arthritis.

Keywords

Rheumatoid arthritis, oxidativestress, vitamin -D

References

Thomson RL Spedding S, Buckley JD (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012 Sep; 77(3):343-50

Krul-Poel, Y.H.; Snackey, C.; Louwers, Y.; Lips, P.; Lambalk, C.B.; Laven, J.S.; Simsek, S (2013). The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: A systematic review. Eur. J. Endocrinol. 169, 853–865.

Thabrew MI, Senaratna L, Samarawickrema N, Munasinghe C (2001). Antioxidant potential of two polyherbal preprations used in Ayurveda for the treatment of rheumatoid arthritis. J Ethnopharmacol ; 76 : 285-91.

Mulherin D, Fitzgerald O, Bresnihan B (1996). Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum; 39 : 115-24.

Sklodowska, M., Gromadzinska, J., Biernacka, M., Wasowicz, W., Wolkanin, P., Marszalek, A., Brozik, H. and Pokuszynska, K (1996). Vitamin E, thiaobarbituric acid reactive substance concentrations and Superoxide Dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clinical and experimental Rheumatology 14, 433-439.

Jones, G., Strugnell, S.A. & Deluca, H.F. (1998) Current understanding of the molecular actions of vitamin D. Physiological Reviews, 78, 1193–1231. 31

Welsh P, M. J. L. Peters, N. Sattar (2011). Is vitamin D in rheumatoid arthritis amagic bullet or mirage the need to improve the evidence base prior to calls for supplementation. Arthritis and Rheumatism, vol.63, no.7, pp.1763–1769.

Boissier M.C, Semerano L, Challal S (2012). Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction. Journal of Autoimmunity; 39: 222-228.

Lundström E, Källberg H, Alfredsson L (2009). Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum ; 60(6): 1597-1603.

Braun-Moscovici Y, Toledan K, Markovits O (2011)Vitamin D: is it related to disease activity in inflammatory joint disease? Rheumatol Int; 31: 493-499.

Agarwal A, Gupta S, Sharma R (2005). Role of oxidative stress in female reproduction. Reprod Biol Endocrinol; 3: 28.

Sabuncu T, Vural H, Harma M, Harma M (2001). Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem ; 34(5): 407-13.

Zhang D, Luo WY, Liao H, Wang CF, Sun Y (2008). The effects of oxidative stress to PCOS. Sichuan Da Xue Xue Bao Yi Xue Ban ; 39(3): 421-3.

Block G, Jensen C, Morrow J, Holland N, Norkus E, Milne G (2008). Effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 15; 45(4): 377–84.

Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002). Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int ; 21 : 200-4.

Darlington L.G. and Stone T.W. (2001) Antioxidants and fatty acids in the amelioration of Rheumatoid arthritis and related disorders. Bri. Journal of Nutr. 85, 251-269.

Rodriguez L. A, L. B. Tolosa, A. Ruigmez, S. Johansson, M. A. Wallander (2009) “Rheumatoid arthritis in UK primary care incidence and prior morbidity,” Scandinavian Journal of Rheumatology,vol.38,no.3,pp.173–177.

Fukuzawa M, J. Satoh, X. Qiang (1999). Inhibition of tumor necrosis factor-

Author Details

Yeluri Naga Siva Jyothi

T. Uma